8-K: HealthEquity Reports Record Revenue, Earnings, Raises 2027 Outlook

HealthEquity announced record revenue and earnings for fiscal year 2026 and the fourth quarter, leading to a raised fiscal 2027 outlook.

Summary

• Fiscal year 2026 revenue increased 9% to $1.31 billion.
• Net income for fiscal year 2026 surged 123% to $215.2 million, with net income margin at 16%.
• Non-GAAP net income per diluted share for fiscal year 2026 increased 28% to $4.00.
• Adjusted EBITDA for fiscal year 2026 grew 20% to $566.0 million, with a 43% margin.
• Total HSA Assets expanded 14% to $36.5 billion as of January 31, 2026.
• The company returned $301.7 million to shareholders through stock repurchases during fiscal year 2026.
• Fourth quarter 2026 revenue increased 7% to $334.6 million.
• Fourth quarter 2026 net income rose 89% to $49.7 million, with a 15% margin.
• Fourth quarter 2026 non-GAAP net income per diluted share increased 38% to $0.95.
• Fourth quarter 2026 Adjusted EBITDA increased 23% to $132.9 million, with a 40% margin.
• HealthEquity added one million new HSAs from sales for the second consecutive year, ending fiscal 2026 with 17.8 million total accounts.
• The company further reduced HSA cash repricing risk with a cumulative $2.35 billion 5-year Treasury bond hedge at 3.92%.

Sentiment

Score: 9

Explanation: StockSavvy.ai views this as a very strong report, characterized by record financial performance, significant growth in key metrics like HSA assets and accounts, and a confident, raised outlook for the next fiscal year, indicating robust operational execution and market position.

Positives

• Record revenue of $1.31 billion for fiscal year 2026, an increase of 9% year-over-year.
• Net income for fiscal year 2026 increased 123% to $215.2 million.
• Net income margin for fiscal year 2026 increased to 16% from 8% in the prior year.
• Non-GAAP net income per diluted share for fiscal year 2026 increased 28% to $4.00.
• Adjusted EBITDA for fiscal year 2026 increased 20% to $566.0 million.
• Adjusted EBITDA margin for fiscal year 2026 increased to 43% from 39% in the prior year.
• Total HSA Assets grew 14% to $36.5 billion as of January 31, 2026.
• Returned $301.7 million to shareholders through stock repurchases during fiscal year 2026.
• Successfully added one million new HSAs from sales for the second consecutive year.
• Total accounts reached 17.8 million, including 10.6 million HSAs (up 7%) and 832,000 HSAs with investments (up 10%).
• Reduced HSA cash repricing risk with a $2.35 billion 5-year Treasury bond hedge at 3.92%.
• Raised fiscal 2027 guidance for revenue, net income, non-GAAP net income, and Adjusted EBITDA.
• Reduced outstanding debt to $957.4 million from $1.06 billion year-over-year.
• Increased cash and cash equivalents to $318.9 million from $295.9 million year-over-year.

Risks

• Ability to adequately place and safeguard custodial assets, or the failure of any depository or insurance company partners.
• Ability to compete effectively in a rapidly evolving healthcare and benefits administration industry.
• Dependence on the continued availability and benefits of tax-advantaged HSAs and other consumer-directed benefits (CDBs).
• Impact of fraudulent account activity involving member accounts or third-party service providers on reputation and financial results.
• Ability to successfully identify, acquire, and integrate additional portfolio purchases or acquisition targets.
• Significant competition faced and may face in the future, including from those with greater resources.
• Reliance on the availability and performance of technology and communications systems.
• Potential future cybersecurity breaches of technology and communications systems and other data interruptions, including resulting costs and liabilities, reputational damage, and loss of business.
• The current uncertain healthcare environment, including changes in healthcare programs and expenditures and related regulations.
• Ability to comply with current and future privacy, healthcare, tax, ERISA, investment adviser, and other laws applicable to the business.
• Reliance on partners and third-party vendors for distribution and important services.
• Ability to develop and implement updated features for technology platforms and communications systems.
• Reliance on the management team and key team members.

Future Outlook

Management has raised its fiscal 2027 guidance, expecting revenues between $1.405 billion and $1.415 billion, net income between $239 million and $246 million ($2.78 to $2.85 per diluted share), non-GAAP net income between $392 million and $400 million ($4.56 to $4.65 per diluted share), and Adjusted EBITDA between $618 million and $628 million. This outlook reflects continued growth and margin expansion, building on record new HSAs from sales and significant operating leverage.

Management Comments

• "We are raising our fiscal 2027 guidance after delivering record new HSAs from sales and significant margin expansion." Scott Cutler, President and CEO of HealthEquity.
• "Adjusted EBITDA increased 23% in the fourth quarter with Adjusted EBITDA margin expanding more than 500 basis points to 40%, reflecting meaningful operating leverage." Scott Cutler.
• "We added one million new HSAs from sales for the second consecutive year and ended fiscal 2026 with 17.8 million total accounts and over $36 billion in HSA assets, positioning us for continued growth." Scott Cutler.

Industry Context

StockSavvy.ai notes that HealthEquity's strong performance, particularly in HSA asset growth and new account acquisition, indicates robust demand for tax-advantaged healthcare savings solutions. The expansion of Adjusted EBITDA margin suggests effective cost management and scalability in a competitive benefits administration landscape, where digital platforms and consumer-directed healthcare are increasingly vital. The strategic hedging of HSA cash repricing risk also demonstrates proactive financial management in a dynamic interest rate environment.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results for direct industry standard comparison.

Stakeholder Impact

• Shareholders: Positive impact due to strong financial performance, increased profitability, significant stock repurchases ($301.7 million), and a raised fiscal 2027 outlook, suggesting potential for continued share price appreciation and shareholder returns.
• Customers (HSA members): Positive impact from continued growth in HSA assets and accounts, implying a robust and expanding platform for managing healthcare savings and benefits.
• Employees: Positive impact from a growing and profitable company, potentially leading to job security and opportunities.
• Depository/Insurance Company Partners: Continued strong relationship and business volume due to growth in HSA cash and assets.

Next Steps

• HealthEquity management will host a conference call on March 17, 2026, at 4:30 pm (Eastern Time) to discuss the fiscal 2026 fourth quarter and year-end results.
• The company plans for continued growth, leveraging its 17.8 million total accounts and over $36 billion in HSA assets.

Key Dates

Recommendation

The filing demonstrates exceptional financial performance with record revenue and earnings, significant margin expansion, and robust growth in HSA assets and accounts. The company's proactive risk management (HSA cash repricing hedge) and substantial shareholder returns through stock repurchases further enhance its appeal. The raised fiscal 2027 guidance signals strong confidence in future growth, making it a compelling "strong buy" for investors seeking exposure to the growing healthcare savings market.

Keywords

HealthEquity, HQY, HSA, Health Savings Account, CDB, Consumer-Directed Benefits, Financial Results, Earnings, Revenue, Adjusted EBITDA, Net Income, Stock Repurchase, Fiscal 2026, Fiscal 2027 Outlook, Healthcare, Benefits Administration, Custodial Assets, Financial Services